5 U.S. Policy Shifts Transforming Lung Cancer Care Access in 2026

added blog Health

2026-02-24 10:09:46 -

The Inflation Reduction Act's drug pricing negotiation framework reached its first lung cancer application in January 2026 when HHS announced the inclusion of a leading EGFR inhibitor in the negotiated drug list — a development reshaping manufacturer pricing strategies globally and prompting urgent formulary reassessment at U.S. payers, pharmacy benefit managers, and hospital pharmacy...

0 Comments 0 Shares 24 Views 0 Reviews